FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging.
about
Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer diseaseMetabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease.The brain, sirtuins, and ageing.A randomized study on the effect of modified behavioral activation treatment for depressive symptoms in rural left-behind elderly.Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging.Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease.
P2860
FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FDG-PET and Neuropsychiatric S ...... he Mayo Clinic Study of Aging.
@en
FDG-PET and Neuropsychiatric S ...... he Mayo Clinic Study of Aging.
@nl
type
label
FDG-PET and Neuropsychiatric S ...... he Mayo Clinic Study of Aging.
@en
FDG-PET and Neuropsychiatric S ...... he Mayo Clinic Study of Aging.
@nl
prefLabel
FDG-PET and Neuropsychiatric S ...... he Mayo Clinic Study of Aging.
@en
FDG-PET and Neuropsychiatric S ...... he Mayo Clinic Study of Aging.
@nl
P2093
P2860
P50
P356
P1476
FDG-PET and Neuropsychiatric S ...... he Mayo Clinic Study of Aging.
@en
P2093
Gorazd B Stokin
Hanna Ruider
Janina Krell-Roesch
Mary M Machulda
Michelle M Mielke
Rosebud O Roberts
Teresa J Christianson
Val J Lowe
Yonas E Geda
P2860
P304
P356
10.3233/JAD-160326
P577
2016-07-14T00:00:00Z